NEW YORK, Dec. 07, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Alere Inc. (“Alere”) (NYSE:ALR) between February 29, 2012 and November 4, 2016. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of Florida. To get more information go to:
http://www.zlk.com/pslra/alere
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that Alere made false and misleading statements and/or failed to disclose: (1) that the Company’s wholly-owned subsidiary, Arriva Medical, LLC (“Arriva”), was submitting claims to Medicare for deceased patients; (2) that this conduct subjected Arriva to revocation of its Medicare enrollment; and (3) that as a result of the above, Alere’s statements about its business, operations, and prospects, were false and misleading and/or lacked a reasonable basis at all relevant times.
On November 4, 2016, Alere disclosed that the Centers for Medicare and Medicaid Services alleged that Arriva submitted claims for 211 deceased patients over a five-year period, and thus revoked Arriva’s Medicare enrollment. Following this new, shares of Alere fell from a close of $42.23 on November 3, 2016, to a close of $36.10 per share.
If you suffered a loss in Alere you have until January 13, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 



